(January 12, 2016, 8:31 AM EST) -- WASHINGTON, D.C. — The U.S. Supreme Court on Jan. 11 declined to decide if its medical device preemption precedents preempt claims involving the off-label use of the Infuse bone graft (Patricia Caplinger v. Medtronic, Inc., et al., No. 15-321, U.S. Sup.)....